Literature DB >> 8035806

Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions.

P A Furth1, W T Choe, J H Rex, J C Byrne, C C Baker.   

Abstract

Expression of bovine papillomavirus type 1 (BPV-1) late genes is limited to terminally differentiated keratinocytes in an infected epithelium. We have previously shown that although the BPV-1 late polyadenylation site is functional in nonpermissive cells, a 53-nucleotide (nt) fragment of the late 3' untranslated region acts posttranscriptionally to reduce polyadenylated cytoplasmic RNA levels. This 53-nt fragment does not appear to function by destabilizing polyadenylated cytoplasmic RNA (P. A. Furth and C. C. Baker, J. Virol. 65:5806-5812, 1991). In this study, we used site-directed mutagenesis and deletion analysis to demonstrate that the sequence AAG/GUAAGU, which is identical to the consensus 5' splice site sequence, was both necessary and sufficient for the inhibitory activity of the 53-nt fragment. Furthermore, base pairing between the 5' end of the U1 small nuclear RNA and this 5' splice site-like sequence was shown to be required for the inhibitory activity in vivo. We have also further mapped the human papillomavirus type 16 late 3' inhibitory element (I. M. Kennedy, J. K. Haddow, and J. B. Clements, J. Virol. 65:2093-2097, 1991) to a 51-nt region containing four overlapping sequence motifs with partial homology to 5' splice sites. Mutation of each of these motifs demonstrated that only one of these motifs is required for the inhibitory activity. However, the presence of the other motifs may contribute to the full inhibitory activity of the element. No BPV-1 or human papillomavirus type 16 mRNAs which are spliced by using the potential 5' splice sites present in the viral late 3' untranslated regions have been identified. This suggests that the primary function of these 5' splice site-like sequences is the inhibition of late gene expression. The most likely mechanism of action of these elements is reduction of polyadenylation efficiency, perhaps through interference with 3'-terminal exon definition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035806      PMCID: PMC359047          DOI: 10.1128/mcb.14.8.5278-5289.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

1.  General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection.

Authors:  X D Fu; A Mayeda; T Maniatis; A R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  Characterization of the mouse beta maj globin transcription termination region: a spacing sequence is required between the poly(A) signal sequence and multiple downstream termination elements.

Authors:  J Tantravahi; M Alvira; E Falck-Pedersen
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

3.  Association with terminal exons in pre-mRNAs: a new role for the U1 snRNP?

Authors:  K M Wassarman; J A Steitz
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

4.  Distinct functions of SR proteins in alternative pre-mRNA splicing.

Authors:  A M Zahler; K M Neugebauer; W S Lane; M B Roth
Journal:  Science       Date:  1993-04-09       Impact factor: 47.728

5.  Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells.

Authors:  A M Carothers; G Urlaub; D Grunberger; L A Chasin
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

6.  Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters.

Authors:  S K Barksdale; C C Baker
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  The human U1 snRNP-specific U1A protein inhibits polyadenylation of its own pre-mRNA.

Authors:  W C Boelens; E J Jansen; W J van Venrooij; R Stripecke; I W Mattaj; S I Gunderson
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

8.  Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Authors:  A Mayeda; D M Helfman; A R Krainer
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

9.  Direct selection for mutations affecting specific splice sites in a hamster dihydrofolate reductase minigene.

Authors:  I T Chen; L A Chasin
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

10.  Short artificial hairpins sequester splicing signals and inhibit yeast pre-mRNA splicing.

Authors:  V Goguel; Y Wang; M Rosbash
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

View more
  90 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Utilization of splicing elements and polyadenylation signal elements in the coupling of polyadenylation and last-intron removal.

Authors:  C Cooke; H Hans; J C Alwine
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Position-dependent inhibition of the cleavage step of pre-mRNA 3'-end processing by U1 snRNP.

Authors:  S Vagner; U Rüegsegger; S I Gunderson; W Keller; I W Mattaj
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

4.  The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.

Authors:  C S Hibbert; R R Gontarek; K L Beemon
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

5.  An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5' splice sites.

Authors:  A J McCullough; S M Berget
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Analysis of inhibitory action of modified U1 snRNAs on target gene expression: discrimination of two RNA targets differing by a 1 bp mismatch.

Authors:  Peng Liu; Amy Gucwa; Mary Louise Stover; Emily Buck; Alexander Lichtler; David Rowe
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

Review 8.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

9.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.

Authors:  S Jeon; P F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fate.

Authors:  Jörg Langemeier; Maximilian Radtke; Jens Bohne
Journal:  RNA Biol       Date:  2013-01-16       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.